Active	Status	Sponsor type	Region	Phase	Filter
2 Active 21 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bein, Berthold
HERO-19, NCT04542408: Hamburg Edoxaban for Anticoagulation in COVID-19 Study	Completed	3	140	Europe	Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or Placebo	Universitätsklinikum Hamburg-Eppendorf	Covid19	09/22	01/23
NCT04260789: Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection	Recruiting	N/A	232	Europe	Seraph 100,The Microbind Affinity Blood Filter	ExThera Medical Europe BV, ExThera Medical Corporation, Vivantes Klinikum Neukölln	Bloodstream Infection	03/22	08/22
Gruenewald, Matthias
No trials found
Ilies, Christoph
No trials found
Hoecker, Jan H
No trials found